Method and formulation for reducing aggregation of a macromolecule under physiological conditions

Details for Australian Patent Application No. 2009313756 (hide)

Owner GENENTECH, INC. F. Hoffmann-La Roche AG

Inventors Lobo, Brian; Lo, Sabrina; Wakankar, Aditya; Wang, Yuchang John; Wong, Rita L.; Goldbach, Pierre; Mahler, Hanns-Christian

Agent Griffith Hack

Pub. Number AU-A-2009313756

PCT Pub. Number WO2010/057109

Priority 61/115,439 17.11.08 US

Filing date 16 November 2009

Wipo publication date 20 May 2010

International Classifications

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/057109 Priority application(s): WO2010/057109

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313759-Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets

2009313754-Method and formulation for reducing aggregation of a macromolecule under physiological conditions